STREAMING NOW: Watch Now

FDA approves new option for cancer patients

Vitrakvi is the first medication developed specifically to target tumors based on gene mutations, not their location in the body.

Posted: Nov 29, 2018 9:24 AM
Updated: Nov 29, 2018 9:44 AM

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.

Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."

The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.

Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.

NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.

Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.

Alongside the tablets, the agency also approved a diagnostic to detect the mutation.

"Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.

AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.

Both treatments were granted Priority Review designation.

Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review.

"A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.

Both treatments also received orphan drug designation, a status granted to drugs for rare diseases or conditions.

Minnesota Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 25208

Reported Deaths: 1060
CountyConfirmedDeaths
Hennepin8514616
Ramsey3075128
Stearns203013
Nobles15445
Anoka142970
Dakota134957
Washington64532
Olmsted63410
Kandiyohi4971
Rice4622
Scott4362
Clay42728
Mower3452
Wright3202
Todd3190
Sherburne2462
Carver2182
Benton1783
Steele1600
Blue Earth1420
Martin1325
Freeborn1250
St. Louis11814
Pine890
Unassigned8810
Nicollet8810
Winona8015
Cottonwood760
Watonwan750
Carlton750
Crow Wing712
Otter Tail700
Goodhue683
Chisago621
Polk612
Lyon570
Itasca5510
Dodge530
Chippewa511
Morrison470
Meeker450
Douglas440
Le Sueur441
Becker400
Murray390
Jackson390
McLeod370
Isanti350
Waseca260
Rock220
Swift190
Mille Lacs191
Pennington190
Faribault190
Wabasha180
Fillmore171
Sibley160
Brown162
Beltrami150
Cass142
Norman130
Marshall120
Pipestone120
Kanabec111
Wilkin113
Wadena100
Koochiching90
Pope90
Aitkin80
Mahnomen61
Yellow Medicine60
Big Stone60
Lincoln50
Redwood50
Renville50
Red Lake40
Grant40
Lac qui Parle30
Clearwater30
Traverse30
Houston20
Hubbard20
Roseau20
Lake10
Kittson10
Stevens10

Iowa Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 19669

Reported Deaths: 555
CountyConfirmedDeaths
Polk4236133
Woodbury276136
Black Hawk174745
Linn95379
Dallas91623
Marshall89616
Buena Vista8100
Johnson6149
Wapello59712
Muscatine55741
Crawford5282
Tama40327
Scott36110
Dubuque34619
Louisa34511
Sioux2830
Pottawattamie2698
Jasper26017
Washington1898
Wright1780
Warren1350
Plymouth1332
Allamakee1204
Story1161
Mahaska9510
Poweshiek908
Henry711
Bremer696
Des Moines651
Boone650
Clinton641
Taylor560
Clarke560
Guthrie513
Cedar481
Benton431
Hamilton430
Webster421
Monroe385
Shelby370
Jones360
Clayton343
Osceola340
Buchanan330
Iowa330
Marion320
Cherokee310
Jefferson300
Cerro Gordo291
Madison292
Lee270
Fayette270
Monona250
Winneshiek240
Lyon240
Davis230
Harrison230
Dickinson210
Sac200
Grundy200
Mills190
Floyd191
Humboldt181
Clay170
Delaware171
Hardin170
Butler171
Lucas170
Emmet160
Hancock160
Appanoose143
Ida140
Page140
Franklin140
Keokuk140
Pocahontas130
Greene130
Howard120
Cass120
Audubon121
Jackson120
Carroll110
Winnebago110
Chickasaw100
Kossuth100
Adair90
Van Buren90
Union90
Montgomery80
Adams70
Palo Alto70
Fremont40
Ringgold40
Mitchell40
Worth30
Calhoun20
Wayne10
Decatur10
Unassigned10
Rochester
Clear
70° wxIcon
Hi: 91° Lo: 62°
Feels Like: 70°
Mason City
Clear
72° wxIcon
Hi: 95° Lo: 64°
Feels Like: 72°
Albert Lea
Clear
72° wxIcon
Hi: 93° Lo: 62°
Feels Like: 72°
Austin
Clear
72° wxIcon
Hi: 95° Lo: 64°
Feels Like: 72°
Charles City
Clear
70° wxIcon
Hi: 93° Lo: 64°
Feels Like: 70°
Powerful storms and summer-like conditions are coming our way
KIMT Radar
KIMT Eye in the sky

Latest Video

${item.thumbnail.title}

StormTeam 3: Today's Severe Weather Update

Image

Yoga studio closes space, tries new idea

Image

Forager Brewery welcomes new business

Image

Salons reopen at 25% capacity

Image

DMC's impact on Rochester's economic recovery

Image

Forager Brewery - best patio in Rochester

Image

Protests in Mason City

Image

Barbershop town hall discusses racial profiling

Image

Minnesota salons reopen

Image

Barbershop Talk: Town hall

Community Events